REDEFINE 1 -- CagriSema phase 3 (Aronne et al., 2025): CagriSema 2.4/2.4 mg produced 22.7% mean weight loss at 68 weeks vs 2.1% placebo
The 3.0mL option creates a 10mg/mL concentration that works for the 4mg and 8mg dose levels but requires splitting at 12mg
(PubMed) Potter K, Hankey GJ, Green DJ, Eikelboom J, Jamrozik K, Arnolda LF
Packaging Details 5mg peptide content per vial Tamper-resistant sealed vial Clearly labeled batch identification Protective packaging during shipment Suitable for research inventory storage systems Shipping methods are designed to help maintain product integrity during transit
Using forceps, the stimulus was applied to the rats hind limb by momentarily pinching the areas innervated by the tibial, fibular, and sural nerves
The chart below shows exact injection volumes for various doses